{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:44:50Z","timestamp":1791571490810,"version":"4.3.4"},"publisher-location":"Berlin, Heidelberg","reference-count":118,"publisher":"Springer Berlin Heidelberg","isbn-type":[{"value":"9783642247156","type":"print"},{"value":"9783642247163","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T00:00:00Z","timestamp":1323475200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,12,10]],"date-time":"2011-12-10T00:00:00Z","timestamp":1323475200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-3-642-24716-3_8","type":"book-chapter","created":{"date-parts":[[2012,1,16]],"date-time":"2012-01-16T12:20:09Z","timestamp":1326716409000},"page":"185-207","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Anorexigenic Effects of GLP-1 and Its Analogues"],"prefix":"10.1007","author":[{"given":"Baptist","family":"Gallwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,10]]},"reference":[{"key":"8_CR1_8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","volume":"1044","author":"CR Abbott","year":"2005","unstructured":"Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR (2005) The inhibitory effects of peripheral administration of peptide YY(3\u201336) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044:127\u2013131","journal-title":"Brain Res"},{"key":"8_CR2_8","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1210\/jc.2008-1296","volume":"94","author":"R Abu-Hamdah","year":"2009","unstructured":"Abu-Hamdah R, Rabiee A, Meneilly GS, Shannon RP, Andersen DK, Elahi D (2009) Clinical review: the extrapancreatic effects of glucagon-like peptide-1 and related peptides. J Clin Endocrinol Metab 94:1843\u20131852","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR3_8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1055\/s-2004-826173","volume":"36","author":"B Ahren","year":"2004","unstructured":"Ahren B (2004) GLP-1 and extra-islet effects. Horm Metab Res 36:842\u2013845","journal-title":"Horm Metab Res"},{"key":"8_CR4_8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","volume":"374","author":"A Astrup","year":"2009","unstructured":"Astrup A, R\u00f6ssner S, Van Gaal L, Rissanen A, Niskanen L, Al Hakim M, Madsen J, Rasmussen MF, Lean ME, NN8022-1807 Study Group (2009) Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374:1606\u20131616","journal-title":"Lancet"},{"key":"8_CR5_8","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","volume":"132","author":"LL Baggio","year":"2007","unstructured":"Baggio LL, Drucker DJ (2007) Biology of incretins: GLP-1 and GIP. Gastroenterology 132:2131\u20132157","journal-title":"Gastroenterology"},{"key":"8_CR6_8","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.2337\/diabetes.53.9.2492","volume":"53","author":"LL Baggio","year":"2004","unstructured":"Baggio LL, Huang Q, Brown TJ, Drucker DJ (2004) A recombinant human glucagon-like peptide (GLP)-1-albumin protein (albugon) mimics peptidergic activation of GLP-1R-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes 53:2492\u20132500","journal-title":"Diabetes"},{"key":"8_CR7_8","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1053\/j.gastro.2008.01.017","volume":"134","author":"LL Baggio","year":"2008","unstructured":"Baggio LL, Huang Q, Cao X, Drucker DJ (2008) An albumin-exendin-4 conjugate engages central and peripheral circuits regulating murine energy and glucose homeostasis. Gastroenterology 134:1137\u20131147","journal-title":"Gastroenterology"},{"key":"8_CR8_8","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nature00887","volume":"418","author":"RL Batterham","year":"2002","unstructured":"Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, Wren AM, Brynes AE, Low MJ, Ghatei MA, Cone RD, Bloom SR (2002) Guthormone PYY(3\u201336) physiologically inhibits food intake. Nature 418:650\u2013654","journal-title":"Nature"},{"key":"8_CR9_8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1056\/NEJMoa030204","volume":"349","author":"RL Batterham","year":"2003","unstructured":"Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR (2003) Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349:941\u2013948","journal-title":"N Engl J Med"},{"key":"8_CR10_8","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1210\/endo.137.10.8828468","volume":"137","author":"SA Beak","year":"1996","unstructured":"Beak SA, Small CJ, Ilovaiskaia I, Hurley JD, Ghatei MA, Bloom SR, Smith DM (1996) Glucagon-like peptide-1 (GLP-1) releases thyrotropin (TSH): characterization of binding sites for GLP-1 on \u03b1-TSH cells. Endocrinology 137:4130\u20134138","journal-title":"Endocrinology"},{"key":"8_CR11_8","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1172\/JCI610","volume":"101","author":"SA Beak","year":"1998","unstructured":"Beak SA, Heath MM, Small CJ, Morgan DG, Ghatei MA, Taylor AD, Buckingham JC, Bloom SR, Smith DM (1998) Glucagon-like peptide-1 stimulates luteinizing hormone-releasing hormone secretion in a rodent hypothalamic neuronal cell line. J Clin Invest 101:1334\u20131341","journal-title":"J Clin Invest"},{"key":"8_CR12_8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/304368a0","volume":"304","author":"GI Bell","year":"1983","unstructured":"Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC (1983) Exon duplication and divergence in the human preproglucagon gene. Nature 304:368\u2013371","journal-title":"Nature"},{"key":"8_CR13_8","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(10)60590-9","volume":"376","author":"RM Bergenstal","year":"2010","unstructured":"Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE (2010) Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. Lancet 376:431\u2013439","journal-title":"Lancet"},{"key":"8_CR14_8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1467-789X.2005.00218.x","volume":"6","author":"MM Boggiano","year":"2005","unstructured":"Boggiano MM, Chandler PC, Oswald KD, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Schindler M, Arndt K, Rudolf K, Mark M, Schoelch C, Joost HG, Klaus S, Thone-Reineke C, Benoit SC, Seeley RJ, Beck-Sickinger AG, Koglin N, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer OJ, Deng XY, Whitcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Ortmann S, Castaneda TR, Tschop M (2005) PYY3-36 as an anti-obesity drug target. Obesity Rev 6:307\u2013322","journal-title":"Obesity Rev"},{"key":"8_CR15_8","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1210\/en.2004-0015","volume":"145","author":"PL Brubaker","year":"2004","unstructured":"Brubaker PL, Drucker DJ (2004) Minireview: glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut, and central nervous system. Endocrinology 145:2653\u20132659","journal-title":"Endocrinology"},{"key":"8_CR16_8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2141\/jpsa.38.35","volume":"38","author":"T Bungo","year":"2001","unstructured":"Bungo T, Ando R, Kawakami S-I, Ohgushi A, Furuse M (2001a) The role of central catecholaminergic systems in regulation of food intake of chicks. J Poult Sci 38:35\u201340","journal-title":"J Poult Sci"},{"key":"8_CR17_8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0091-3057(01)00613-X","volume":"70","author":"T Bungo","year":"2001","unstructured":"Bungo T, Kawakami S-I, Ohgushi A, Sashihara K, Saito N, Sugahara K, Hasegawa S, Denbow DM, Furuse M (2001b) Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like peptide-1 in the neonatal chick. Pharmacol Biochem Behav 70:251\u2013255","journal-title":"Pharmacol Biochem Behav"},{"key":"8_CR18_8","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2337\/dc09-1914","volume":"33","author":"JB Buse","year":"2010","unstructured":"Buse JB, Drucker DJ, Taylor KL, Kim T, Walsh B, Hu H, Wilhelm K, Trautmann M, Shen LZ, Porter LE (2010) DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52\u00a0weeks. Diabetes Care 33:1255\u20131261","journal-title":"Diabetes Care"},{"key":"8_CR19_8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/13543784.2011.562191","volume":"20","author":"M Christensen","year":"2011","unstructured":"Christensen M, Knop FK, Vilsb\u00f8ll T, Holst JJ (2011) Lixisenatide for type 2 diabetes mellitus. Expert Opin Investig Drugs 20:549\u2013557","journal-title":"Expert Opin Investig Drugs"},{"key":"8_CR20_8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1023\/A:1015396825274","volume":"19","author":"VT Chuang","year":"2002","unstructured":"Chuang VT, Kragh-Hansen U, Otagiri M (2002) Pharmaceutical strategies utilizing recombinant human serum albumin. Pharm Res 19:569\u2013577","journal-title":"Pharm Res"},{"key":"8_CR21_8","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/j.1464-5491.2008.02484.x","volume":"25","author":"JP Courreges","year":"2008","unstructured":"Courreges JP, Vilsboll T, Zdravkovic M, Le-Thi T, Krarup T, Schmitz O, Verhoeven R, Buganova I, Madsbad S (2008) Beneficial effects of once-daily liraglutide, a human glucagon-like peptide-1 analogue, on cardiovascular risk biomarkers in patients with Type 2 diabetes. Diabet Med 25:1129\u20131131","journal-title":"Diabet Med"},{"key":"8_CR22_8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01225454","volume":"16","author":"W Creutzfeldt","year":"1979","unstructured":"Creutzfeldt W (1979) The incretin concept today. Diabetologia 16:75\u201385","journal-title":"Diabetologia"},{"key":"8_CR23_8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.soard.2007.02.003","volume":"3","author":"D Cummings","year":"2007","unstructured":"Cummings D, Overduin J, Foster-Schubert K, Carlson M (2007) Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis 3:109\u2013115","journal-title":"Surg Obes Relat Dis"},{"key":"8_CR24_8","first-page":"137","volume-title":"Obesity surgery: principles and practice","author":"D Cummings","year":"2008","unstructured":"Cummings D, Foster-Schubert K, Carlson M, Shannon M, Overduin J (2008) Possible hormonal mechanisms mediating the effects of bariatric surgery. In: Pitomobo C, Jones K, Higa K, Pareja J (eds) Obesity surgery: principles and practice. McGraw-Hill, New York, NY, pp 137\u2013147"},{"key":"8_CR25_8","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1177\/0148607108322401","volume":"32","author":"D D\u2019Alessio","year":"2008","unstructured":"D\u2019Alessio D (2008) Intestinal hormones and regulation of satiety: the case for CCK, GLP-1, PYY, and Apo A-IV. JPEN J Parenter Enteral Nutr 32:567\u2013568","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"8_CR26_8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1172\/JCI118380","volume":"97","author":"DA D\u2019Alessio","year":"1996","unstructured":"D\u2019Alessio DA, Vogel R, Prigeon R, Laschansky E, Koerker D, Eng J, Ensinck JW (1996) Elimination of the action of glucagon-like peptide 1 causes an impairment of glucose tolerance after nutrient ingestion by healthy baboons. J Clin Invest 97:133\u2013138","journal-title":"J Clin Invest"},{"key":"8_CR27_8","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1210\/en.2003-1338","volume":"145","author":"CL Dakin","year":"2004","unstructured":"Dakin CL, Small CJ, Batterham RL, Neary NM, Cohen MA, Patterson M, Ghatei MA, Bloom SR (2004) Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology 145:2687\u20132695","journal-title":"Endocrinology"},{"key":"8_CR28_8","doi-asserted-by":"crossref","first-page":"G424","DOI":"10.1152\/ajpgi.2002.282.3.G424","volume":"282","author":"S Delgado-Aros","year":"2002","unstructured":"Delgado-Aros S, Kim DY, Burton DD, Thomforde GM, Stephens D, Brinkmann BH, Vella A, Camilleri M (2002) Effect of GLP-1 on gastric volume, emptying, maximum volume ingested, and postprandial symptoms in humans. Am J Physiol Gastrointest Liver Physiol 282:G424\u2013G431","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"8_CR29_8","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/S0140-6736(10)60406-0","volume":"375","author":"M Diamant","year":"2010","unstructured":"Diamant M, Van GL, Stranks S, Northrup J, Cao D, Taylor K, Trautmann M (2010) Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial. Lancet 375:2234\u20132243","journal-title":"Lancet"},{"key":"8_CR30_8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2337\/dc09-1374","volume":"33","author":"C Dirksen","year":"2010","unstructured":"Dirksen C, Hansen DL, Madsbad S, Hvolris LE, Naver LS, Holst JJ, Worm D (2010) Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report. Diabetes Care 33:375\u2013377","journal-title":"Diabetes Care"},{"key":"8_CR31_8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","volume":"3","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ (2006) The biology of incretin hormones. Cell Metab 3:153\u2013165","journal-title":"Cell Metab"},{"key":"8_CR32_8","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","volume":"368","author":"DJ Drucker","year":"2006","unstructured":"Drucker DJ, Nauck MA (2006) The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368:1696\u20131705","journal-title":"Lancet"},{"key":"8_CR33_8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","volume":"372","author":"DJ Drucker","year":"2008","unstructured":"Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang D, Porter L (2008) Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet 372:1240\u20131250","journal-title":"Lancet"},{"key":"8_CR34_8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/mi.8.2.5","volume":"8","author":"JM Egan","year":"2008","unstructured":"Egan JM, Margolskee RF (2008) Taste cells of the gut and gastrointestinal chemosensation. Mol Interv 8:78\u201381","journal-title":"Mol Interv"},{"key":"8_CR35_8","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1056\/NEJM198205203062002","volume":"306","author":"D Elahi","year":"1982","unstructured":"Elahi D, Nagulesparan M, Hershcopf RJ, Muller DC, Tobin JD, Blix PM, Rubenstein AH, Unger RH, Andres R (1982) Feedback inhibition of insulin secretion by insulin: relation to the hyperinsulinemia of obesity. N Engl J Med 306:1196\u20131202","journal-title":"N Engl J Med"},{"key":"8_CR36_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/endo.130.1.1309325","volume":"130","author":"HC Fehmann","year":"1992","unstructured":"Fehmann HC, Habener JF (1992) Insulinotropic hormone glucagon-like peptide-I(7\u201337) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells. Endocrinology 130:159\u2013166","journal-title":"Endocrinology"},{"key":"8_CR37_8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","volume":"101","author":"A Flint","year":"1998","unstructured":"Flint A, Raben A, Astrup A, Holst JJ (1998) Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101:515\u2013520","journal-title":"J Clin Invest"},{"key":"8_CR38_8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/sj.ijo.0801627","volume":"25","author":"A Flint","year":"2001","unstructured":"Flint A, Raben A, Ersb\u00f8ll AK, Holst JJ, Astrup A (2001) The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes Relat Metab Disord 25:781\u2013792","journal-title":"Int J Obes Relat Metab Disord"},{"key":"8_CR39_8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0014-2999(97)01391-5","volume":"339","author":"M Furuse","year":"1997","unstructured":"Furuse M, Matsumoto M, Saito N, Sugahara K, Hasegawa S (1997) The central corticotropin-releasing factor and glucagon-like peptide-1 in food intake of the neonatal chick. Eur J Pharmacol 339:211\u2013213","journal-title":"Eur J Pharmacol"},{"key":"8_CR40_8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(08)61246-5","volume":"373","author":"A Garber","year":"2009","unstructured":"Garber A, Henry R, Ratner R, Garcia-Hernandez PA, Rodriguez-Pattzi H, Olvera-Alvarez I, Hale PM, Zdravkovic M, Bode B (2009) Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised,52-week, phase III, double-blind, parallel-treatment trial. Lancet 373:473\u2013481","journal-title":"Lancet"},{"key":"8_CR41_8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1463-1326.2010.01356.x","volume":"13","author":"A Garber","year":"2011","unstructured":"Garber A, Henry RR, Ratner R, Hale P, Chang CT, Bode B, LEAD-3 (Mono) Study Group (2011) Liraglutide, a once-daily human glucagon-like peptide 1 analogue, provides sustained improvements in glycaemic control and weight for 2 years as monotherapy compared with glimepiride in patients with type 2 diabetes. Diabetes Obes Metab 13:348\u2013356","journal-title":"Diabetes Obes Metab"},{"key":"8_CR42_8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/dmrr.1080","volume":"26","author":"W Glaesner","year":"2010","unstructured":"Glaesner W, Vick AM, Millican R, Ellis B, Tschang SH, Tian Y, Bokvist K, Brenner M, Koester A, Porksen N, Etgen G, Bumol T (2010) Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein. Diabetes Metab Res Rev 26:287\u2013296","journal-title":"Diabetes Metab Res Rev"},{"key":"8_CR43_8","doi-asserted-by":"crossref","first-page":"19650","DOI":"10.1016\/S0021-9258(19)36565-2","volume":"268","author":"R G\u00f6ke","year":"1993","unstructured":"G\u00f6ke R, Fehmann HC, Linn T, Schmidt H, Krause M, Eng J, G\u00f6ke B (1993) Exendin-4 is a high potency agonist and truncated exendin-(9\u201339)-amide an antagonist at the glucagon-like peptide 1-(7\u201336)-amide receptor of insulin-secreting beta-cells. J Biol Chem 268:19650\u201319655","journal-title":"J Biol Chem"},{"key":"8_CR44_8","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1111\/j.1460-9568.1995.tb00650.x","volume":"7","author":"R G\u00f6ke","year":"1995","unstructured":"G\u00f6ke R, Larsen PJ, Mikkelsen JD, Sheikh SP (1995) Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7:2294\u20132300","journal-title":"Eur J Neurosci"},{"key":"8_CR45_8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0014-5793(95)01070-U","volume":"373","author":"J Gromada","year":"1996","unstructured":"Gromada J, Rorsman P, Dissing S, Wulff BS (1996) Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release. FEBS Lett 373:182\u2013186","journal-title":"FEBS Lett"},{"key":"8_CR46_8","first-page":"R1541","volume":"276","author":"JP Gutzwiller","year":"1999","unstructured":"Gutzwiller JP, Drewe J, Goke B, Schmidt H, Rohrer B, Lareida J, Beglinger C (1999) Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. Am J Physiol 276:R1541\u2013R1544","journal-title":"Am J Physiol"},{"key":"8_CR47_8","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","volume":"87","author":"JJ Holst","year":"2007","unstructured":"Holst JJ (2007) The physiology of glucagon-like peptide 1. Physiol Rev 87:1409\u20131439","journal-title":"Physiol Rev"},{"key":"8_CR48_8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.molmed.2008.01.003","volume":"14","author":"JJ Holst","year":"2008","unstructured":"Holst JJ, Deacon CF, Vilsb\u00f8ll T, Krarup T, Madsbad S (2008) Glucagon-like peptide-1, glucose homeostasis and diabetes. Trends Mol Med 14:161\u2013168","journal-title":"Trends Mol Med"},{"key":"8_CR49_8","first-page":"G920","volume":"273","author":"N Imery\u00fcz","year":"1997","unstructured":"Imery\u00fcz N, Yeden BC, Bozkurt A, Copkun T, Villanueva-Pe\u00f1acarrillo ML, Ulusoy NB (1997) Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol 273:G920\u2013G927","journal-title":"Am J Physiol"},{"key":"8_CR50_8","doi-asserted-by":"crossref","first-page":"15069","DOI":"10.1073\/pnas.0706890104","volume":"104","author":"HJ Jang","year":"2007","unstructured":"Jang HJ, Kokrashvili Z, Theodorakis MJ, Carlson OD, Kim BJ, Zhou J, KimHH XuX, Chan SL, Juhaszova M, Bernier M, Mosinger B, Margolskee RF, Egan JM (2007) Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1. Proc Natl Acad Sci USA 104:15069\u201315074","journal-title":"Proc Natl Acad Sci USA"},{"key":"8_CR51_8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/cne.902710405","volume":"271","author":"SL Jin","year":"1988","unstructured":"Jin SL, Han VK, Simmons JG, Towle AC, Lauder JM, Lund PK (1988) Distribution of glucagonlike peptide I (GLP-I), glucagon, and glicentin in the rat brain: an immunocytochemical study. J Comp Neurol 271:519\u2013532","journal-title":"J Comp Neurol"},{"key":"8_CR52_8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1566-0702(02)00182-0","volume":"102","author":"M Kakei","year":"2002","unstructured":"Kakei M, Yada T, Nakagawa A, Nakabayashi H (2002) Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons. Auton Neurosci 102:39\u201344","journal-title":"Auton Neurosci"},{"key":"8_CR53_8","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ijo.2009.254","volume":"34","author":"SR Kashyap","year":"2010","unstructured":"Kashyap SR, Daud S, Kelly KR, Gastaldelli A, Win H, Brethauer S, Kirwan JP, Schauer PR (2010) Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 34:462\u2013471","journal-title":"Int J Obes (Lond)"},{"key":"8_CR54_8","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc06-2375","volume":"30","author":"D Kim","year":"2007","unstructured":"Kim D, Macconell L, Zhuang D, Kothare PA, Trautmann M, Fineman M, Taylor K (2007) Effects of once-weekly dosing of a long-acting release formulation of exenatide on glucose control and body weight in subjects with type 2 diabetes. Diabetes Care 30:1487\u20131493","journal-title":"Diabetes Care"},{"key":"8_CR55_8","doi-asserted-by":"crossref","first-page":"10470","DOI":"10.1523\/JNEUROSCI.22-23-10470.2002","volume":"22","author":"KP Kinzig","year":"2002","unstructured":"Kinzig KP, D\u2019Alessio DA, Seeley RJ (2002) The diverse roles of specific GLP-1Rs in the control of food intake and the response to visceral illness. J Neurosci 22:10470\u201310476","journal-title":"J Neurosci"},{"key":"8_CR56_8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1185\/030079908X253870","volume":"24","author":"DC Klonoff","year":"2008","unstructured":"Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG (2008) Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3\u00a0years. Curr Med Res Opin 24:275\u2013286","journal-title":"Curr Med Res Opin"},{"key":"8_CR57_8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0306-4522(96)00434-4","volume":"77","author":"PJ Larsen","year":"1997","unstructured":"Larsen PJ, Tang-Christensen M, Holst JJ, \u00d8rskov C (1997a) Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257\u2013270","journal-title":"Neuroscience"},{"key":"8_CR58_8","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1210\/endo.138.10.5270","volume":"138","author":"PJ Larsen","year":"1997","unstructured":"Larsen PJ, Tang-Christensen M, Jessop DS (1997b) Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat. Endocrinology 138:4445\u20134455","journal-title":"Endocrinology"},{"key":"8_CR59_8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s004280000374","volume":"438","author":"Z Ling","year":"2001","unstructured":"Ling Z, Wu D, Zambre Y, Flamez D, Drucker DJ, Pipeleers DG, Schuit FC (2001) Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice. Virchows Arch 438:382\u2013387","journal-title":"Virchows Arch"},{"key":"8_CR60_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2008.07.003","volume":"151","author":"H Linnebjerg","year":"2008","unstructured":"Linnebjerg H, Park S, Kothare PA, Trautmann ME, Mace K, Fineman M, Wilding I, Nauck M, Horowitz M (2008) Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes. Regul Pept 151:123\u2013129","journal-title":"Regul Pept"},{"key":"8_CR61_8","doi-asserted-by":"crossref","first-page":"7125","DOI":"10.1523\/JNEUROSCI.1025-07.2007","volume":"27","author":"X Ma","year":"2007","unstructured":"Ma X, Bruning J, Ashcroft FM (2007) Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons. J Neurosci 27:7125\u20137129","journal-title":"J Neurosci"},{"key":"8_CR62_8","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.beem.2009.03.008","volume":"23","author":"S Madsbad","year":"2009","unstructured":"Madsbad S (2009) Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics) - preclinical and clinical results. Best Pract Res Clin Endocrinol Metab 23:463\u2013477","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"8_CR63_8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/j.1463-1326.2011.01357.x","volume":"13","author":"S Madsbad","year":"2011","unstructured":"Madsbad S, Kielgast U, Asmar M, Deacon C, Torekov SS, Holst JJ (2011) An overview of once-weekly GLP-1 receptor agonists - available efficacy and safety data and perspectives for the future. Diabetes Obes Metab 13:394\u2013407","journal-title":"Diabetes Obes Metab"},{"key":"8_CR64_8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1210\/endo.140.1.6421","volume":"140","author":"K Meeran","year":"1999","unstructured":"Meeran K, O\u2019Shea D, Edwards CM, Turton MD, Heath MM, Gunn I, Abusnana S, Rossi M, Small CJ, Goldstone AP, Taylor GM, Sunter D, SteereJ CSJ, Ghatei MA, Bloom SR (1999) Repeated intracerebroventricular administration of glucagon-like peptide-1-(7\u201336) amide or exendin-(9\u201339) alters body weight in the rat. Endocrinology 140:244\u2013250","journal-title":"Endocrinology"},{"key":"8_CR65_8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0014-2999(02)01434-6","volume":"440","author":"JJ Meier","year":"2002","unstructured":"Meier JJ, Gallwitz B, Schmidt WE, Nauck MA (2002) Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives. Eur J Pharmacol 440:269\u2013279","journal-title":"Eur J Pharmacol"},{"key":"8_CR66_8","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1210\/jc.2003-030049","volume":"88","author":"JJ Meier","year":"2003","unstructured":"Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE, Nauck MA (2003a) Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2719\u20132725","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR67_8","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1055\/s-2003-42658","volume":"35","author":"S Meier","year":"2003","unstructured":"Meier S, H\u00fccking K, Ritzel R, Holst JJ, Schmiegel WH, Nauck MA (2003b) Absence of a memory effect for the insulinotropic action of glucagon-like peptide 1 (GLP-1) in healthy volunteers. Horm Metab Res 35:551\u2013556","journal-title":"Horm Metab Res"},{"key":"8_CR68_8","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.2337\/diabetes.54.7.2212","volume":"54","author":"JJ Meier","year":"2005","unstructured":"Meier JJ, Kemmeries G, Holst JJ, Nauck MA (2005) Erythromycin antagonizes the deceleration of gastric emptying by glucagon-like peptide 1 and unmasks its insulinotropic effect in healthy subjects. Diabetes 54:2212\u20132218","journal-title":"Diabetes"},{"key":"8_CR69_8","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.2337\/diacare.26.10.2835","volume":"26","author":"GS Meneilly","year":"2003","unstructured":"Meneilly GS, Greig N, Tildesley H, Habener JF, Egan JM, Elahi D (2003) Effects of 3\u00a0months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care 26:2835\u20132841","journal-title":"Diabetes Care"},{"key":"8_CR70_8","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00006676-200403000-00004","volume":"28","author":"K Nagai","year":"2004","unstructured":"Nagai K, Tsuchiya K, Ezaki T, Tsuchiya M, Ohgawara H (2004) Effect of GLP-1 (glucagon-like peptide 1:7\u201336 amide) on porcine pancreatic endocrine cell proliferation and insulin secretion. Pancreas 28:138\u2013145","journal-title":"Pancreas"},{"key":"8_CR71_8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2006.06.090","volume":"1111","author":"Y Nakade","year":"2006","unstructured":"Nakade Y, Tsukamoto K, Pappas TN, Takahashi T (2006) Central glucagon like peptide-1 delays solid gastric emptying via central CRF and peripheral sympathetic pathway in rats. Brain Res 1111:117\u2013121","journal-title":"Brain Res"},{"key":"8_CR72_8","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.ijo.0800818","volume":"23","author":"E N\u00e4slund","year":"1999","unstructured":"N\u00e4slund E, Barkeling B, King N, Gutniak M, Blundell JE, Holst JJ, R\u00f6ssner S, Hellstr\u00f6m PM (1999) Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes Relat Metab Disord 23:304\u2013311","journal-title":"Int J Obes Relat Metab Disord"},{"key":"8_CR73_8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1079\/BJN20031064","volume":"91","author":"E N\u00e4slund","year":"2004","unstructured":"N\u00e4slund E, King N, Mansten S, Adner N, Holst JJ, Gutniak M, Hellstr\u00f6m PM (2004) Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects. Br J Nutr 91:439\u2013446","journal-title":"Br J Nutr"},{"key":"8_CR74_8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","volume":"29","author":"M Nauck","year":"1986","unstructured":"Nauck M, St\u00f6ckmann F, Ebert R, Creutzfeldt W (1986) Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29:46\u201352","journal-title":"Diabetologia"},{"key":"8_CR75_8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/BF00401145","volume":"36","author":"MA Nauck","year":"1993","unstructured":"Nauck MA, Kleine N, \u00d8rskov C, Holst JJ, Willms B, Creutzfeldt W (1993) Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7\u201336 amide) in type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:741\u2013744","journal-title":"Diabetologia"},{"key":"8_CR76_8","first-page":"E981","volume":"273","author":"MA Nauck","year":"1997","unstructured":"Nauck MA, Niedereichholz U, Ettler R, Holst JJ, \u00d8rskov C, Ritzel R, Schmiegel WH (1997) Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol 273:E981\u2013E988","journal-title":"Am J Physiol"},{"key":"8_CR77_8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1007\/BF00274797","volume":"30","author":"C \u00d8rskov","year":"1987","unstructured":"\u00d8rskov C, Holst JJ, Poulsen SS, Kirkegaard P (1987) Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874\u2013881","journal-title":"Diabetologia"},{"key":"8_CR78_8","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diab.45.6.832","volume":"45","author":"C \u00d8rskov","year":"1996","unstructured":"\u00d8rskov C, Poulsen SS, Moller M, Holst JJ (1996) Glucagon-like peptide I receptors in the subfornical organ and the area postrema are accessible to circulating glucagon-like peptide I. Diabetes 45:832\u2013835","journal-title":"Diabetes"},{"key":"8_CR79_8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.surg.2007.03.001","volume":"142","author":"A Patrita","year":"2007","unstructured":"Patrita A, Aisa M, Annetti C, Sidoni A, Galli F, Ferri I, Gull\u00e0 N, Donini A (2007) How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and \u03b2-cell function in Goto-kakizaki rats through enhanced proglucagon gene expression and L-cell number. Surgery 142:74\u201385","journal-title":"Surgery"},{"key":"8_CR80_8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2982.2004.00528.x","volume":"16","author":"S Pellissier","year":"2004","unstructured":"Pellissier S, Sasaki K, Le-Nguyen D, Bataille D, Jarrousse C (2004) Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestine. Neurogastroenterol Motil 16:455\u2013463","journal-title":"Neurogastroenterol Motil"},{"key":"8_CR81_8","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/SLA.0b013e3181ae32e3","volume":"250","author":"R Peterli","year":"2009","unstructured":"Peterli R, W\u00f6lnerhanssen B, Peters T, Devaux N, Kern B, Christoffel-Courtin C, Drewe J, von Fl\u00fce M, Beglinger C (2009) Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial. Ann Surg 250:234\u2013241","journal-title":"Ann Surg"},{"key":"8_CR82_8","volume-title":"Obesity surgery: principles and practice","author":"C Pitomobo","year":"2008","unstructured":"Pitomobo C (2008) Central nervous system regulation and hormonal signaling. In: Pitomobo C, Jones K, Higa K, Pareja C (eds) Obesity surgery: principles and practice. McGraw-Hill, New York, NY"},{"key":"8_CR83_8","doi-asserted-by":"crossref","first-page":"21432","DOI":"10.1016\/S0021-9258(19)36628-1","volume":"267","author":"JP Raufman","year":"1992","unstructured":"Raufman JP, Singh L, Singh G, Eng J (1992) Truncated glucagon-like peptide-1 interacts with exendin receptors on dispersed acini from guinea pig pancreas. Identification of a mammalian analogue of the reptilian peptide exendin-4. J Biol Chem 267:21432\u201321437","journal-title":"J Biol Chem"},{"key":"8_CR84_8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1677\/joe.1.06557","volume":"191","author":"RA Reimer","year":"2006","unstructured":"Reimer RA (2006) Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1\/2 and p38 mitogen-activated protein kinases. J Endocrinol 191:159\u2013170","journal-title":"J Endocrinol"},{"key":"8_CR85_8","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2337\/dc09-0366","volume":"32","author":"J Rosenstock","year":"2009","unstructured":"Rosenstock J, Reusch J, Bush M, Yang F, Stewart M (2009) Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing. Diabetes Care 32:1880\u20131886","journal-title":"Diabetes Care"},{"key":"8_CR86_8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/01.sla.0000133117.12646.48","volume":"240","author":"F Rubino","year":"2004","unstructured":"Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E (2004) The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism. Ann Surg 240:236\u2013242","journal-title":"Ann Surg"},{"key":"8_CR87_8","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1210\/jc.2008-0605","volume":"93","author":"M Salehi","year":"2008","unstructured":"Salehi M, Vahl TP, D\u2019Alessio DA (2008) Regulation of islet hormone release and gastric emptying by endogenous GLP-1 following glucose ingestion. J Clin Endocrinol Metab 93:4909\u20134916","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR88_8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1172\/JCI118411","volume":"97","author":"J Schirra","year":"1996","unstructured":"Schirra J, Katschinski M, Weidmann C, Sch\u00e4fer T, Wank U, Arnold R, G\u00f6ke B (1996) Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 97:92\u2013103","journal-title":"J Clin Invest"},{"key":"8_CR89_8","first-page":"84","volume":"109","author":"J Schirra","year":"1997","unstructured":"Schirra J, Kuwert P, Wank U, Leicht P, Arnold R, G\u00f6ke B, Katschinski M (1997) Differential effects of subcutaneous GLP-1 on gastric emptying, antroduodenal motility, and pancreatic function in men. Proc Assoc Am Physicians 109:84\u201397","journal-title":"Proc Assoc Am Physicians"},{"key":"8_CR90_8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/gut.2004.059741","volume":"55","author":"J Schirra","year":"2006","unstructured":"Schirra J, Nicolaus M, Roggel R, Katschinski M, Storr M, Woerle HJ, G\u00f6ke B (2006) Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans. Gut 55:243\u2013251","journal-title":"Gut"},{"key":"8_CR91_8","first-page":"G423","volume":"267","author":"J Schmidtler","year":"1994","unstructured":"Schmidtler J, Dehne K, Allescher HD, Schusdziarra V, Classen M, Holst JJ, Polack A, Schepp W (1994) Rat parietal cell receptors for GLP-1-(7\u201336) amide: Northern blot, cross-linking, and radioligand binding. Am J Physiol 267:G423\u2013G432","journal-title":"Am J Physiol"},{"key":"8_CR92_8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/vhrm.2006.2.1.69","volume":"2","author":"CA Schnabel","year":"2006","unstructured":"Schnabel CA, Wintle M, Kolterman O (2006) Metabolic effects of the incretin mimetic exenatide in the treatment of type 2 diabetes. Vasc Health Risk Manag 2:69\u201377","journal-title":"Vasc Health Risk Manag"},{"key":"8_CR93_8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","volume":"404","author":"MW Schwartz","year":"2000","unstructured":"Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661\u2013671","journal-title":"Nature"},{"key":"8_CR94_8","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1523\/JNEUROSCI.20-04-01616.2000","volume":"20","author":"RJ Seeley","year":"2000","unstructured":"Seeley RJ, Blake K, Rushing PA, Benoit S, Eng J, Woods SC, D\u2019Alessio D (2000) The role of CNS glucagon-like peptide-1 (7\u201336) amide receptors in mediating the visceral illness effects of lithium chloride. J Neurosci 20:1616\u20131621","journal-title":"J Neurosci"},{"key":"8_CR95_8","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1507\/endocrj.K08E-091","volume":"55","author":"S Seo","year":"2008","unstructured":"Seo S, Ju S, Chung H, Lee D, Park S (2008) Acute effects of glucagon-like peptide-1 on hypothalamic neuropeptide and AMP activated kinase expression in fasted rats. Endocr J 55:867\u2013874","journal-title":"Endocr J"},{"key":"8_CR96_8","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1471-4159.2008.05397.x","volume":"106","author":"YK Shin","year":"2008","unstructured":"Shin YK, Martin B, Golden E, Dotson CD, Maudsley S, Kim W, Jang HJ, Mattson MP, Drucker DJ, Egan JM, Munger SD (2008) Modulation of taste sensitivity by GLP-1 signaling. J Neurochem 106:455\u2013463","journal-title":"J Neurochem"},{"key":"8_CR97_8","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1210\/endo.137.11.8895391","volume":"137","author":"PJ Shughrue","year":"1996","unstructured":"Shughrue PJ, Lane MV, Merchenthaler I (1996) Glucagon-like peptide-1 receptor (GLP1-R) mRNA in the rat hypothalamus. Endocrinology 137:5159\u20135162","journal-title":"Endocrinology"},{"key":"8_CR98_8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(03)01692-3","volume":"469","author":"RA Silvestre","year":"2003","unstructured":"Silvestre RA, Rodr\u00edguez-Gallardo J, Egido EM, Marco J (2003) Interrelationship among insulin, glucagon and somatostatin secretory responses to exendin-4 in the perfused rat pancreas. Eur J Pharmacol 469:195\u2013200","journal-title":"Eur J Pharmacol"},{"key":"8_CR99_8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.cardfail.2006.08.211","volume":"12","author":"GG Sokos","year":"2006","unstructured":"Sokos GG, Nikolaidis LA, Mankad S, Elahi D, Shannon RP (2006) Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. J Card Fail 12:694\u2013699","journal-title":"J Card Fail"},{"key":"8_CR100_8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1517\/14712598.2010.481281","volume":"10","author":"EL St Onge","year":"2011","unstructured":"St Onge EL, Miller SA (2011) Albiglutide: a new GLP-1 analog for the treatment of type 2 diabetes. Expert Opin Biol Ther 10:801\u2013806","journal-title":"Expert Opin Biol Ther"},{"key":"8_CR101_8","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1210\/endo.141.6.7490","volume":"141","author":"M Szayna","year":"2000","unstructured":"Szayna M, Doyle ME, Betkey JA, Holloway HW, Spencer RG, Greig NH, Egan JM (2000) Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats. Endocrinology 141:1936\u20131941","journal-title":"Endocrinology"},{"key":"8_CR102_8","first-page":"R848","volume":"271","author":"M Tang-Christensen","year":"1996","unstructured":"Tang-Christensen M, Larsen PJ, G\u00f6ke R, Fink-Jensen A, Jessop DS, M\u00f8ller M, Sheikh SP (1996) Central administration of GLP-1-(7\u201336) amide inhibits food and water intake in rats. Am J Physiol 271:R848\u2013R856","journal-title":"Am J Physiol"},{"key":"8_CR103_8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diabetes.47.4.530","volume":"47","author":"M Tang-Christensen","year":"1998","unstructured":"Tang-Christensen M, Vrang N, Larsen PJ (1998) Glucagon-like peptide 1(7\u201336) amide\u2019s central inhibition of feeding and peripheral inhibition of drinking are abolished by neonatal monosodium glutamate treatment. Diabetes 47:530\u2013537","journal-title":"Diabetes"},{"issue":"Suppl. 1","key":"8_CR104_8","first-page":"A103","volume":"55","author":"K Thibaudeau","year":"2006","unstructured":"Thibaudeau K, Robitaille M, Wen S et al (2006) CJC-1134-PC: an exendin-4 conjugate with extended pharmacodynamic profiles in rodents. Diabetes 55(suppl 1):A103","journal-title":"Diabetes"},{"key":"8_CR105_8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0884533610361739","volume":"25","author":"S Thomas","year":"2010","unstructured":"Thomas S, Schauer P (2010) Bariatric surgery and the gut hormone response. Nutr Clin Pract 25:175\u2013182","journal-title":"Nutr Clin Pract"},{"key":"8_CR106_8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nature02665","volume":"430","author":"M Tsch\u00f6p","year":"2004","unstructured":"Tsch\u00f6p M, Castaneda T, Joost HG, Th\u00f6ne-Reineke C, Ortmann S, Klaus S, Hagan HH, Chandler PC, Oswald KD, Benoit SC, Seeley RJ, Kinzig KP, Moran TH, Beck-Sickinger AG, Koglin N, Rodgers RJ, Blundell JE, Ishii Y, Beattie AH, Holch P, Allison DB, Raun K, Madsen K, Wulff BS, Stidsen CE, Birringer M, Kreuzer O, Schindler M, Arndt K, Rudolf K, Mark M, Deng XY, Withcomb DC, Halem H, Taylor J, Dong J, Datta R, Culler M, Craney S, Flora D, Smiley D, Heiman ML (2004) Does gut hormone PYY3-36 decrease food intake in rodents? Nature 430:165\u2013166","journal-title":"Nature"},{"key":"8_CR107_8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/379069a0","volume":"379","author":"MD Turton","year":"1996","unstructured":"Turton MD, O\u2019Shea D, Gunn I, Beak SA, Edwards CM, Meeran K, Choi SJ, Taylor GM, Heath MM, Lambert PD, Wilding JP, Smith DM, Ghatei MA, Herbert J, Bloom SR (1996) A role for glucagon-like peptide-1 in the central regulation of feeding. Nature 379:69\u201372","journal-title":"Nature"},{"key":"8_CR108_8","first-page":"R1096","volume":"271","author":"G Van Dijk","year":"1996","unstructured":"Van Dijk G, Thiele TE, Donahey JC, Campfield LA, Smith FJ, Burn P, Bernstein IL, Woods SC, Seeley RJ (1996) Central infusions of leptin and GLP-1-(7\u201336) amide differentially stimulate c-FLI in the rat brain. Am J Physiol 271:R1096\u2013R1100","journal-title":"Am J Physiol"},{"key":"8_CR109_8","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.2337\/db07-0136","volume":"56","author":"A Vella","year":"2007","unstructured":"Vella A, Bock G, Giesler PD, Burton DB, Serra DB, Saylan ML, Dunning BE, Foley JE, Rizza RA, Camilleri M (2007) Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes. Diabetes 56:1475\u20131480","journal-title":"Diabetes"},{"key":"8_CR110_8","first-page":"4382","volume":"86","author":"C Verdich","year":"2001","unstructured":"Verdich C, Flint A, Gutzwiller JP, N\u00e4slund E, Beglinger C, Hellstr\u00f6m PM, Long SJ, Morgan LM, Holst JJ, Astrup A (2001) A meta-analysis of the effect of glucagon-like peptide-1 (7\u201336) amide on ad libitum energy intake in humans. J Clin Endocrinol Metab 86:4382\u20134389","journal-title":"J Clin Endocrinol Metab"},{"key":"8_CR111_8","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-150-2-200901200-00007","volume":"150","author":"ML Vetter","year":"2009","unstructured":"Vetter ML, Cardillo S, Rickels MR, Iqbal N (2009) Narrative review: effect of bariatric surgery on type 2 diabetes mellitus. Ann Intern Med 150:94\u2013103","journal-title":"Ann Intern Med"},{"key":"8_CR112_8","doi-asserted-by":"crossref","first-page":"R470","DOI":"10.1152\/ajpregu.00732.2002","volume":"285","author":"N Vrang","year":"2003","unstructured":"Vrang N, Phifer CB, Corkern MM, Berthoud HR (2003) Gastric distension induces c-Fos in medullary GLP-1\/2-containing neurons. Am J Physiol Regul Integr Comp Physiol 285:R470\u2013R478","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"8_CR113_8","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.neuroimage.2007.11.008","volume":"39","author":"GJ Wang","year":"2008","unstructured":"Wang GJ, Tomasi D, Backus W, Wang R, Telang F, Geliebter A, Korner J, Bauman A, Fowler JS, Thanos PK, Volkow ND (2008) Gastric distention activates satiety circuitry in the human brain. Neuroimage 39:1824\u20131831","journal-title":"Neuroimage"},{"issue":"Suppl. 1","key":"8_CR114_8","first-page":"A148","volume":"58","author":"M Wang","year":"2009","unstructured":"Wang M, Matheson S, Picard J, Pezzullo J, Ulich T (2009) PC-DAC (TM): exendin-4 (CJC-1134-PC) significantly reduces HbA1c and body weight as an adjunct therapy to metformin: two randomized, double-blind, placebo-controlled, 12\u00a0week, phase II studies in patients with type 2 diabetes mellitus. Diabetes 58(suppl 1):A148","journal-title":"Diabetes"},{"key":"8_CR115_8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1124\/mol.109.055244","volume":"76","author":"P Wellendorph","year":"2009","unstructured":"Wellendorph P, Johansen LD, Brauner-Osborne H (2009) Molecular pharmacology of promiscuous seven transmembrane receptors sensing organic nutrients. Mol Pharmacol 76:453\u2013465","journal-title":"Mol Pharmacol"},{"key":"8_CR116_8","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.40.5.597","volume":"40","author":"A Wettergren","year":"1997","unstructured":"Wettergren A, W\u00f8jdemann M, Meisner S, Stadil F, Holst JJ (1997) The inhibitory effect of glucagon-like peptide-1 (GLP-1) 7\u201336 amide on gastric acid secretion in humans depends on an intact vagal innervation. Gut 40:597\u2013601","journal-title":"Gut"},{"key":"8_CR117_8","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diabetes.48.5.1026","volume":"48","author":"AA Young","year":"1999","unstructured":"Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B, Denaro M (1999) Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob\/ob, db\/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macacamulatta). Diabetes 48:1026\u20131034","journal-title":"Diabetes"},{"key":"8_CR118_8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","volume":"359","author":"M Zander","year":"2002","unstructured":"Zander M, Madsbad S, Madsen JL, Holst JJ (2002) Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and \u03b2-cell function in type 2 diabetes: a parallel-group study. Lancet 359:824\u2013830","journal-title":"Lancet"}],"container-title":["Handbook of Experimental Pharmacology","Appetite Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-642-24716-3_8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T02:32:43Z","timestamp":1674181963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-642-24716-3_8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,10]]},"ISBN":["9783642247156","9783642247163"],"references-count":118,"URL":"https:\/\/doi.org\/10.1007\/978-3-642-24716-3_8","relation":{},"ISSN":["0171-2004","1865-0325"],"issn-type":[{"value":"0171-2004","type":"print"},{"value":"1865-0325","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,10]]},"assertion":[{"value":"10 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}